Published in Am J Surg on January 01, 1978
The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann Surg (1984) 3.08
Resection of hepatic metastases from colorectal cancer. Biologic perspective. Ann Surg (1989) 2.79
Hepatic resection for colorectal liver metastases. Influence on survival of preoperative factors and surgery for recurrences in 80 patients. Ann Surg (1987) 2.58
Major hepatic resection for metachronous metastases from colon cancer. Ann Surg (1985) 1.89
Patterns of failure following surgical resection of colorectal cancer liver metastases. Rationale for a multimodal approach. Ann Surg (1987) 1.46
Current treatment for liver metastases from colorectal cancer. World J Gastroenterol (2003) 1.28
Hepatic resection of metastasis from colorectal carcinoma. Morbidity, mortality, and pattern of recurrence. Ann Surg (1989) 1.22
Hepatic resection for metastatic colon and rectal cancer. An evaluation of preoperative and postoperative factors. Ann Surg (1985) 1.19
Radiofrequence ablation of liver cancers. World J Gastroenterol (2002) 1.08
Treatment of cancer of the liver. Twenty years' experience with infusion and resection in 414 patients. Ann Surg (1988) 0.95
Delivery of RNA nanoparticles into colorectal cancer metastases following systemic administration. ACS Nano (2015) 0.92
The role of postoperative pelvic radiation in stage IV rectal cancer after resection of primary tumor. Radiat Oncol J (2012) 0.85
Incurable stenosing colorectal carcinoma: endoscopic stent implantation or palliative surgery? World J Surg (2006) 0.85
Resection of liver metastases from a colorectal carcinoma does not benefit the patient. Ann R Coll Surg Engl (1990) 0.81
Hepatic resection, hepatic arterial infusion pump therapy, and genetic biomarkers in the management of hepatic metastases from colorectal cancer. J Gastrointest Oncol (2015) 0.81
Referral patterns of patients with liver metastases due to colorectal cancer for resection. Int J Colorectal Dis (2008) 0.81
The role of adjuvant pelvic radiotherapy in rectal cancer with synchronous liver metastasis: a retrospective study. Radiat Oncol (2010) 0.81
Treatment of colorectal hepatic metastases by intrahepatic chemotherapy alone or as an adjuvant to complete or partial removal of metastatic disease. Ann Surg (1986) 0.75
Younger women with breast carcinoma have a poorer prognosis than older women. Cancer (1996) 3.54
Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol (2000) 3.42
Malignant melanoma of the extremities: a clinicopathologic study using levels of invasion (microstage). Cancer (1975) 3.26
Malignant peripheral nerve sheath tumors. A clinicopathologic study of 28 cases. Cancer (1993) 2.89
Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. N Engl J Med (1978) 2.69
Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg (1996) 2.68
Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol (2001) 2.06
Giant condyloma acuminatum (Buschke-Lowenstein tumor) of the anorectal and perianal regions. Analysis of 42 cases. Dis Colon Rectum (1994) 2.04
The effect of surgical wounding on tumour development. Eur J Surg Oncol (1999) 1.88
Proceedings: Treatment of minimal breast cancer. Cancer (1974) 1.78
Anorectal melanoma. Cancer (1981) 1.77
Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions. J Am Coll Surg (1996) 1.77
Paraproteinemia and reticulum cell sarcoma in an inbred mouse strain. Science (1966) 1.65
Selection of the optimum surgical treatment of stage I melanoma by depth of microinvasion: Use of the combined microstage technique (Clark-Breslow). Ann Surg (1975) 1.52
Hepatic resection for metastasis from colorectal cancer. Dis Colon Rectum (1978) 1.44
T-cell deficiency in patients with squamous cell cancer of the head and neck. Am J Surg (1975) 1.40
Immunogenic properties of reticulum cell sarcomas of SJL/J mice. J Natl Cancer Inst (1970) 1.30
Diagnosis and management of giant intrasacral schwannoma. Cancer (1992) 1.28
A rationale for expanding the endpoints for clinical trials in advanced pancreatic carcinoma. Cancer (1996) 1.27
Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma. Ann Surg (1995) 1.24
Bilateral breast cancer. Risk reduction by contralateral biopsy. Ann Surg (1985) 1.22
Wound-induced tumor progression: a probable role in recurrence after tumor resection. Arch Surg (1998) 1.22
Recurrent thyroid cancer. Role of surgery versus radioactive iodine (I131) Ann Surg (1994) 1.21
Results of surgical treatment of nonhepatic recurrence of colorectal carcinoma. Cancer (1993) 1.20
Decreased complement mediated binding of antibody/3H-dsDNA immune complexes to the red blood cells of patients with systemic lupus erythematosus, rheumatoid arthritis, and hematologic malignancies. Arthritis Rheum (1983) 1.19
Abdominal sacral resection of locally recurrent rectal cancer. Ann Surg (1981) 1.16
Immunologic reactivity in patients with primary operable breast cancer. Cancer (1978) 1.10
Randomized comparison of cyclophosphamide, imidazole carboxamide, and adriamycin versus cyclophosphamide and adriamycin in patients with advanced stage malignant mesothelioma: a Sarcoma Intergroup Study. J Clin Oncol (1987) 1.08
Pelvic recurrence of rectal cancer. Options for curative resection. Ann Surg (1987) 1.07
Is carcinoma of the gallbladder a curable lesion? Ann Surg (1982) 1.05
Pelvic exenteration for recurrent rectal cancer. Adv Surg (1996) 1.02
Are carcinoembryonic antigen levels of value in the curative management of colorectal cancer? Surgery (1981) 1.00
Pleural mesothelioma. Cancer (1976) 0.99
Consensus guidelines from The American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States. Ann Surg Oncol (2013) 0.97
Prognostic factors and management considerations in patients with cervical metastases of thyroid cancer. Am J Surg (1992) 0.97
Isolated pelvic perfusion for unresectable cancer using a balloon occlusion technique. Arch Surg (1993) 0.97
The acute and chronic effects of alcohol on the human immune system. Surg Gynecol Obstet (1975) 0.96
Fine needle aspiration cytology in lieu of open biopsy in management of primary breast cancer. Ann Surg (1984) 0.96
Surgical management and treatment of gastric and duodenal fistulas. Surg Clin North Am (1996) 0.96
Thyroid cancer: some basic considerations. Am J Surg (1981) 0.95
Immune reactivity in patients with colorectal cancer: assessment of biologic risk by immunoparameters. Cancer (1980) 0.95
Rectal injuries. J Trauma (1969) 0.94
Prognostic evaluation of regional lymph node morphology colorectal cancer. Am J Surg (1975) 0.93
Thin < or = 1 mm level III and IV melanomas are higher risk lesions for regional failure and warrant sentinel lymph node biopsy. Ann Surg Oncol (2000) 0.92
Surgical adjuvant therapy of malignant melanoma with corynebacterium parvum. Cancer (1981) 0.92
Intravenous Corynebacterium parvum: an adjunct to chemotherapy for resistant advanced ovarian cancer. Cancer (1977) 0.91
Immunologic reactivity and prognosis in breast cancer. Cancer (1980) 0.91
Production of and response to interleukin-2 in peripheral blood lymphocytes of cancer patients. Cancer (1986) 0.91
The impact of histopathology on nodal metastases in minimal breast cancer. Arch Surg (1997) 0.91
Colonoscopy: an essential monitoring technique after resection of colorectal cancer. Am J Surg (1983) 0.91
Localized carcinoma of the external ear is an unrecognized aggressive disease with a high propensity for local regional recurrence. Am J Surg (1992) 0.90
Age correlates with increased frequency of high risk factors in elderly patients with thyroid cancer. Am J Surg (1995) 0.90
Prognostic and therapeutic use of microstaging of cutaneous squamous cell carcinoma of the trunk and extremities. Cancer (1985) 0.90
Optimal surgical treatment of invasive lobular carcinoma of the breast. Ann Surg Oncol (1998) 0.89
Cancer of the anal canal. Curr Probl Cancer (1980) 0.89
Squamous cell carcinoma in the immunosuppressed patient: Fanconi's anemia. Laryngoscope (1985) 0.89
Prognostic analysis of survival in small breast cancers. J Am Coll Surg (1998) 0.88
Multimodality approach to surgical management of locally advanced epidermoid carcinoma of the anorectum. Cancer (1981) 0.87
Paclitaxel and concurrent radiation for gastric cancer. Int J Radiat Oncol Biol Phys (2000) 0.87
Preoperative radiation therapy for rectal cancer. An effective therapy in need of a clinical trial. Arch Surg (1986) 0.87
Randomized trial of Bacillus Calmette-Guérin (percutaneous administration) as surgical adjuvant immunotherapy for patients with stage-II melanoma. Ann N Y Acad Sci (1976) 0.86
Lupus erythematosus complicated by the Chiari-Frommel syndrome and autoimmune thyroiditis. Arch Intern Med (1969) 0.85
Colorectal cancer. A blueprint for disease control through screening by primary care physicians. Arch Surg (1986) 0.85
Interleukin-10 as a possible mediator of immunosuppressive effect in patients with squamous cell carcinoma of the head and neck. Ann Surg Oncol (1997) 0.84
Reconstruction of full thickness chest wall defects. Ann Surg (1988) 0.84
Paclitaxel, cisplatin, and concurrent radiation for esophageal cancer. Cancer Invest (2001) 0.83
Cancer of the bile duct: the occult malignancy. Am J Surg (1975) 0.83
Paclitaxel and concurrent radiation for locally advanced pancreatic and gastric cancer: a phase I study. J Clin Oncol (1997) 0.83
Suspected recurrent rectosigmoid carcinoma after abdominoperineal resection: MR imaging and histopathologic findings. Radiology (1989) 0.83
Catheter tract seeding after percutaneous biliary drainage for pancreatic cancer. Cancer (1986) 0.82
Regression in thin malignant melanoma. Microscopic diagnosis and prognostic importance. Arch Dermatol (1985) 0.82
Delayed hypersensitivity reactions in patients with carcinoma of the colon and rectum. Surg Gynecol Obstet (1977) 0.82
Technique and guidelines for needle localization biopsy of nonpalpable lesions of the breast. Surg Gynecol Obstet (1988) 0.82
Primary gastric lymphoma. Problems in staging and management. Am J Surg (1988) 0.82
Synchronous colon carcinomas: molecular-genetic evidence for multicentricity. Ann Surg Oncol (1996) 0.82
Severe hypoglycemia associated with terminal lymphomas. Report of five cases. Cancer (1966) 0.81
Antitumor effects of a normal human serum factor (normal human globulin fraction 1) on human tumor cells in vitro. J Natl Cancer Inst (1984) 0.81
Immunologic evaluation and prognosis in patients with head and neck cancer. Am J Surg (1977) 0.81
Preoperative chemotherapy and radiation therapy for stage IIIa carcinoma of the lung. Ann Thorac Surg (1992) 0.81
Arteriovenous fistulas of major vessels in the abdomen. J Trauma (1971) 0.81
Intralesional injection of the methanol extraction residue of Bacillus Calmette-Guerin (MER) into cutaneous metastases of malignant melanoma. Cancer (1978) 0.81
The influence of incubation time and mitogen concentration on lymphocyte blastogenic response: determination of conditions that maximize population differences. J Immunol (1980) 0.81
The changing mammogram. A primary indication for needle localization biopsy. Arch Surg (1986) 0.80
Evaluation of the pathologic and prognostic correlates of estrogen receptors in primary breast cancer. Ann Surg (1982) 0.80
Systemic and adjuvant therapy for patients with pancreatic carcinoma. Cancer (1996) 0.80
Repeat hepatic resection for recurrent colorectal cancer. World J Surg (1997) 0.79
Alterations of monocyte function in neoplastic diseases. Surg Forum (1979) 0.79
Immune reactivity in primary carcinoma of the lung and its relation to prognosis. J Thorac Cardiovasc Surg (1976) 0.79
Electron microscopy of murine SJL-J disease. Int J Cancer (1969) 0.79
Seroma prevention using fibrin glue during modified radical neck dissection in a rat model. Am J Surg (1988) 0.79
A new mouse model of experimental melanoma for vaccine and lymphokine therapy. Int J Oncol (1998) 0.79
DNCB reactivity and prognosis in 419 patients with malignant melanoma. Cancer (1981) 0.78
Immunocompetence testing in patients with one of the four common operable cancers--a review. Clin Bull (1978) 0.78
Changing gastric cancer treatment in the United States and the pursuit of quality. Eur J Surg Oncol (2005) 0.78
The impact of an educational workshop on colorectal screening practices. J Cancer Educ (1987) 0.78
Bile duct carcinoma. Diagnosis and treatment. Ann Surg (1985) 0.78
Molecular oncogene markers and their significance in cutaneous malignant melanoma. Ann Surg Oncol (1998) 0.78